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Abstract
Pseudomonas aeruginosa is a common hospital-acquired pathogen and is often associated
with high mortality rates due to the development of multidrug-resistance. Antimicrobial
plant-derived (phyto-) aldehydes present a promising alternative to antibiotics due to their
broad-spectrum antimicrobial activity and low propensity to trigger resistance. However, two
main problems preclude the widespread application of these compounds: chemical instability
and low antimicrobial efficacy. The ongoing collaboration between the Mavrodi and Patton
labs at USM has recently addressed the problem of chemical instability by incorporating
plant aldehydes into polymer materials called Pro-Antimicrobial Networks via Degradable
Acetals (PANDAs). Thus, this study aimed to address the low antimicrobial efficacy of
phytoaldehydes. The first step involved the characterization of cellular pathways targeted by
4-methoxybenzaldehyde, which is a metabolite from star anise and a key component of
PANDAs. Pseudomonas aeruginosa PAO1 was subjected to transposon mutagenesis and
10,000 mutants were screened for hypersensitivity to 4-methoxybenzaldehyde. Results of the
screening revealed that inactivation of the MexAB-OprM multidrug efflux pump sensitizes
P. aeruginosa to phytoaldehydes. Based onthis finding, several plant-derived efflux pump
inhibitors (EPIs) were tested for the capacity to improve the antimicrobial efficacy of 4methoxybenzaldehyde. Results of this testing revealed that epigallocatechin gallate (EGCG)
from green tea acted synergistically with 4-methoxybenzaldehyde and significantly reduced
its minimal inhibitory concentration. Finally, the response of four medically important P.
aeruginosa efflux pump genes to 4-methoxybenzaldehyde and EGCG was analyzed using
RT-qPCR. The result demonstrated that the phytoaldehyde significantly upregulated
MexCD-OprJ and MexEF-OprN efflux pumps and the addition of EGCG reversed this effect.
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Collectively, our results highlighted the importance of active efflux in the resistance of P.
aeruginosa to phytoaldehydes and the potential of EPIs in improving the efficacy of these
natural antimicrobials.

Keywords: Pseudomonas aeruginosa, multidrug efflux pumps, 4-methoxybenzaldehyde,
essential oil, efflux pump inhibitor, minimal inhibitory concentration
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1. Introduction
The rapid emergence of antibiotic resistance in pathogenic bacteria has become a
major global concern over the past few decades. The increase in antibiotic-resistant clinical
isolates coupled with the lag in the development of effective antimicrobials poses a serious
threat to human medicine in the upcoming years (Fernández & Hancock, 2012). The report
published by the Centers for Disease Control and Prevention (CDC) (2013) states that
antibiotic-resistant bacteria infect at least 2 million people and as a result, at least 23,000
people die annually in the United States.
The Gram-negative bacterium Pseudomonas aeruginosa is an opportunistic human
pathogen that is increasingly becoming multidrug-resistant and causes nosocomial
pneumonia, as well as bloodstream, urinary tract and surgical site infections (Hidron et al.,
2008). According to the CDC report in 2013, this pathogen was implicated in 8% of
nosocomial infections in the US, with multidrug-resistant isolates responsible for 13% of
cases of severe infections. The 2015 report by European Centre for Disease Prevention and
Control states that approximately 14% of isolates reported between 2005 and 2013 in Europe
were not responsive to multiple antibiotic treatments.
Plant-derived essential oil (EO) contains multiple constituents that exhibit a broad
range of antimicrobial activity and can potentially substitute antibiotics due to the low
propensity to trigger resistance (Bassole and Juliani, 2012). Besides, many essential oils are
harmless to humans and are classified by the Food and Drug Administration as Generally
Recognized as Safe substances (Topuz et al., 2016). EOs could be potentially used as food
preservatives and disinfectants, but poor water solubility, volatility, and chemical instability
preclude the widespread practical application of these compounds (Fernandez-Lopez &
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Viuda-Martos, 2018). The collaborative research by the Patton lab in the School of Polymer
Science and Engineering and the Mavrodi lab in the School of Biological, Environmental and
Earth Sciences at The University of Southern Mississippi has addressed these drawbacks by
incorporating plant aldehydes into Pro-Antimicrobial Networks via Degradable Acetals
(PANDAs), which are polymeric materials that release antimicrobials in response to changes
in pH and humidity in the environment (Amato et al., 2017a). PANDAs provide a sustained
release of the volatile EO constituents resulting in the prolonged exposure of bacteria to plant
antimicrobials and inhibition of their growth (Amato et al., 2017b).
Recently, the antimicrobial activity of several EO-derived aldehydes in P. aeruginosa
PAO1 has been characterized (Amato et al., 2018). The results revealed that the compound
with the highest antimicrobial activity was 4-methoxybenzaldehyde (p-anisaldehyde), a
natural antimicrobial found in the seeds of star anise (Pimpinella anisum) (Amato et al.,
2018). 4-methoxybenzaldehyde was also used as a key component of PANDAs that kill
various fungal and bacterial pathogens, including multidrug-resistant P. aeruginosa (Amato
et al., 2017b). Since the mode of action and cellular targets of plant-derived antimicrobial
aldehydes are poorly understood, Amato et al., (2018) generated 3,000 transposon mutants of
P. aeruginosa PAO1 and screened them for hypersensitivity to 4-methoxybenzaldehyde and
other EO-derived aldehydes. The screen revealed that mutations in genes involved in various
transport and biosynthetic pathways, including those encoding the MexA membrane fusion
protein of the MexAB-OprM efflux pump and OprF porin, resulted in a decrease in minimal
inhibitory concentration (MIC) of EO-derived aldehydes (Amato et al., 2018). The first goal
of my project was to generate 7,000 additional mutants, which helped to increase the overall
coverage of P. aeruginosa PAO1 genes by transposon insertions to approximately 83%.
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Results of my experiments identified the cell envelope as a major target of 4methoxybezaldehyde and revealed other cellular pathways that contribute to the resistance of
P. aeruginosa to this plant-derived antimicrobial.
Although plant-derived antimicrobial aldehydes present many advantages, they have
lower antimicrobial efficacy compared to antibiotics and require larger amounts to eradicate
microbial populations effectively. Given the relevance of efflux pumps for the susceptibility
of P. aeruginosa to 4-methoxybezaldehyde, I hypothesized that efflux pump inhibitors (EPIs)
could be used to improve the antimicrobial efficacy of phytoaldehydes. Several types of
synthetic EPIs were demonstrated to lower MICs and potentiate the activity of clinical
antibiotics. However, the cytotoxicity of these compounds precludes their use in antibiotic
therapy, and there is a need for non-toxic, effective and broad-spectrum EPIs (Puzari &
Chetia, 2017). Accordingly, the second goal of my project was to test several natural EPIs,
including geraniol, berberine, epigallocatechin gallate (EGCG), daidzein and curcumin, for
their ability to potentiate the activity of 4-methoxybenzaldehyde. Results of these tests
revealed that epigallocatechin gallate, a compound found in green tea, acted synergistically
and reduced the MIC of 4-methoxybenzaldehyde by 60%.
Numerous studies have addressed the contribution of multidrug efflux pump systems
to the resistance of bacterial pathogens to certain classes of antibiotics (Puzari & Chetia,
2017). The genome of P. aeruginosa encodes multiple RND-type efflux pumps that
contribute to the intrinsic antibiotic tolerance of this pathogen. However, the role of RNDtype efflux pumps in contributing to the resistance to natural plant-derived antimicrobials is
less well understood. To address this deficiency, I investigated the response of four P.
aeruginosa efflux pumps to 4-methoxybenzaldehyde, EGCG, and their combination using
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RT-qPCR assay. My results revealed that 4-methoxybenzaldehyde significantly upregulated
genes for MexCD-OprJ and MexEF-OprN efflux pumps. Treatment with EGCG reversed the
inducing effect of 4-methoxybenzaldehyde highlighting the importance of active efflux in the
resistance of P. aeruginosa to phytoaldehydes, and the potential of EPIs for improving the
efficacy of these natural antimicrobials.

2. Literature Review
2.1.

Pseudomonas aeruginosa

Pseudomonas aeruginosa is a ubiquitous Gram-negative bacterium that inhabits
various environments such as soil and surfaces in aqueous habitats (Gellatly & Hancock,
2013). It is highly adaptable and possesses intrinsic resistance to antimicrobials, which
allows it to survive in both natural and artificial environments, including surfaces in medical
facilities (Gellatly & Hancock, 2013). Pseudomonas aeruginosa can transform into an
opportunistic pathogen and cause both acute or chronic infections in humans and animals
(Chugani and Greenberg 2007; Rutherford and Bassler, 2012). The infections caused by P.
aeruginosa are often hospital-acquired and involve neutropenia, severe burns, or pneumonia
in cystic fibrosis patients (Lyczak et al., 2000; Gellatly & Hancock, 2013). Multidrugresistant P. aeruginosa is classified as a severe threat, with 6,700 infections and 440 deaths
per year in the U.S. (CDC, 2013).
Pseudomonas aeruginosa possesses a variety of mechanisms that contribute to its
intrinsic and acquired resistance to antimicrobials. It secretes β-lactamases that mediate the
resistance to β-lactam antibiotics, such as penicillin, cephalosporins, carbapenems, and
monobactams (Poole, 2011). All four described molecular classes of β-lactamases (i.e., class
4

B metal-dependent Zn2+-requiring and class A, C, and D metal-independent) have been found
in P. aeruginosa (Zhao and Hu, 2010; Poole, 2011). In addition to β-lactamases, efflux
systems, especially those from the resistance-nodulation-division (RND) family, play an
essential role in the antimicrobial resistance of this pathogen (Poole, 2007; Poole, 2011). Last
but not least, changes in the permeability of the outer membrane through mutations together
with biofilms further increase resistance to some antimicrobials (Poole, 2011). As antibiotics
are becoming less efficient by ever-increasing resistance, the search for alternative natural
antimicrobial compounds is on the rise.
2.2.

Essential oils (EOs)

Essential oils (EOs) are complex mixtures of volatile secondary metabolites produced
by aromatic plants. The first evidence of humans using EO-producing plants dates back to
10,000 BC and is based on pollen analyses of Stone Age settlements (Baser and Buchbauer,
2015). The aromatic odor and healing properties of EOs have been mainly utilized through
the usage of aromatic plants as spices and remedies for the treatment of illnesses (Baser and
Buchbauer, 2015; Guenther, 1948). The long history of EO application in medicine is
evidenced by Papyrus Ebers, a medical document from ancient Egypt from 1,550 BC,
containing around 700 formulas and remedies made with aromatic plants and their products
(Baser and Buchbauer, 2015).
The first development of the distillation of EOs is credited to the Catalan physician
Arnaldus de Villanova (1235-1311), and his approach made a significant contribution to
medieval European therapy (Guenther, 1948). Later, the Swiss medical reformer Bombastus
Paracelsus von Hohenheim (1493-1541) proposed the theory that distillation released the
very last and desirable extractive, the Quinta essentia (quintessence), which is the most
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critical part of every drug (Guenther, 1948). His theory inspired further research into the
properties of EOs, and the term “essential oil” was derived from the concept of Quinta
essentia (Guenther, 1948). Over the course of the last half-century, EO constituents have
been studied extensively, and our knowledge in this field has rapidly expanded.
In terms of composition, EOs represent complex natural mixtures containing 20–60
chemically distinct components at varying concentrations (Bakkali et al., 2008). Two or three
of these components constitute 20–70% of an EO, while the remaining constituents are
present in trace amounts (Bakkali et al., 2008). Most essential oils contain terpenes
(oxygenated or not) that are composed of isoprene units and exist in acyclic, monocyclic,
bicyclic and tricyclic forms (Swamy et al., 2016). The terpenes are classified into several
groups such as monoterpenes (C10H16), sesquiterpenes (C15H24), diterpenes (C20H32), and
triterpenes (C30H40), with monoterpenes and sesquiterpenes prevailing (~90%) in bioactive
EOs (Swamy et al., 2016; Miguel, 2010). Other EO constituents are represented by
terpenoids, and allyl- and propenylphenols (phenylpropanoids) (Swamy et al., 2016; Miguel,
2010).
In nature, EOs serve several important ecological roles. They attract desirable insects
that disperse pollen or seeds and repel the undesirable ones. Essential oils also act as
defensive substances against microorganisms and herbivores, and mediate allelopathic
communication between plants (Bakkali et al., 2008; Miguel, 2010). Human use of EOs
includes their application as antibacterials, antivirals, antifungals, insecticides and herbicides
(Burt, 2004; Miguel, 2010). In medicine, EOs are used as components of anticancer,
antinociceptive, antiphlogistic, antiviral, antibacterial and antioxidant products (Buchbauer,
2010). Some EOs have antioxidant properties and can be used to prevent diseases caused by
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free radicals, such as brain dysfunction, cancer, heart disease, immune system decline, and
inflammatory responses (Aruoma, 1998; Kamatou and Viljoen, 2010; Miguel, 2010). The
antioxidant properties of EOs also reflect their use as food preservatives (Miguel, 2010).
Due to their complex composition, the EOs do not have a particular cellular target
(Carson et al., 2002; Bakkali et al., 2008). Most EOs are hydrophobic and can exhibit some
level of cytotoxicity associated with the leakage of macromolecules and cell lysis (Bakkali et
al., 2008). As antimicrobials, EOs were reported to function by disrupting membrane
integrity, ATP synthesis, protein and quorum sensing pathways (Nazzaro et al., 2013; Yap et
al., 2014; Amato et al., 2017b). In bacteria, EOs also can coagulate cytoplasm (Gustafson et
al., 1998) and affect the interactions of lipids and proteins in the membrane (Ultee et al.,
2002; Burt, 2004). Due to multiple targets of EOs, no particular resistance or adaptation to
EOs has been described so far (Bakkali et al., 2008).
2.3.

4-methoxybenzaldehyde (p-anisaldehyde)

4-methoxybenzaldehyde is a metabolite from seeds of star anise (Pimpinella anisum),
which is a standard part of the diet in Northern India and is widely cultivated in the
Mediterranean basin and South Asia (Shi et al., 2017). This phytoaldehyde exhibits
antifungal activity against several species of yeast and molds in laboratory media, fruit
purees, and fruit juices (Lu et al., 2010, Shreaz et al., 2011). This compound also exhibits
fungicidal, as opposed to fungistatic activity against the wild-type and antibiotic-resistant
strains of Candida spp. (Shreaz et al., 2011). The combined treatment by 4methoxybenzaldehyde and bacteriocin nisin was shown to have a long-term inhibitory effect
on the growth of the Gram-positive bacterium Staphylococcus aureus (Shi et al., 2017). The
compound has also been shown to act synergistically with nisin against Listeria
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monocytogenes, which is a common and economically important food-borne pathogen (Zhao
et al., 2016).
2.4.

Pro-Antimicrobial Networks via Degradable Acetals (PANDAs)

Many components of EOs, including phytoaldehydes, are hydrophobic and highly
volatile (Turek & Stintzing, 2013). In anise oil, 4-methoxybenzaldehyde is one of the major
volatile compounds that constitute approximately 0.42% of this EO (Topuz et al., 2016).
Amato et al. (2017b) recently addressed this problem of volatility and instability of
phytoaldehydes by incorporating them into Pro-Antimicrobial Networks via Degradable
Acetals (PANDAs) via thiol-ene photopolymerization. Thiol-ene allows step-wise addition of
4-methoxybenzaldehyde acetal and therefore, the occupation of every cross-link junction by
the acetal ( Amato et al., 2017b). The degradation of PANDAs is triggered by low pH and
humidity and results in the release of the active antimicrobial 4-methoxybenzaldehyde and
inactive low molecular weight degradation byproducts (Figure 1) (Amato et al., 2017a).
PANDAs were shown to have antimicrobial effect against both bacterial and fungal
pathogens, including P. aeruginosa PAO1, Salmonella typhimurium ATCC 6539,
Escherichia coli ATCC 43895 (serotype O157:H7), and Histoplasma capsulatum G217B,
and exhibited a minimum cytotoxic effect on KB (HeLa) cells ( Amato et al., 2017b). The
concept was further improved by synthesizing co-PANDAs, which combine synergistically
interacting 4-methoxybenzaldehyde and 4-bromobenzaldehyde (Amato et al., 2018). The coPANDAs have higher antimicrobial activity and negligible cytotoxicity to mammalian cells
(Amato et al., 2018). Despite the increased antimicrobial activity of co-PANDA, there is
potential to further improve PANDAs by incorporating natural compounds that target
important structures or pathways in microbes.
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p-anisaldehyde

Humidity

Acyclic diallyl
p-anisaldehyde
acetal

pH<8

Pentaerythritol 3mercaptopropionate
(PETMP)

Figure 1. Synthesis of PANDAs and their degradation. The scheme is adapted from Amato
et al. (2018).
2.5.

Multidrug efflux pumps

Efflux pumps are membrane transporter proteins that represent a significant
component of the intrinsic and acquired antibiotic resistance mechanisms in P. aeruginosa
(Poole, 2011). When antibiotics reach the intracellular milieu of the bacterial cell, they are
rapidly expelled by efflux pumps, which allows the organism to survive (Lomovskaya et al.,
2001). While drug-specific efflux pump genes are harbored in mobile genetic elements,
multidrug-resistance pumps are encoded on bacterial chromosomes, signifying their function
in natural bacterial environments (Lomovskaya et al., 2001, Fernández & Hancock, 2012).
There are two main classes of efflux pumps: ATP-binding cassette (ABC) transporters and
secondary multidrug transporters (Fernández & Hancock, 2012). The ABC transporters use
the energy released from the hydrolysis of ATP to move solutes across the membrane,
facilitating the uptake of nutrients against a concentration gradient (Schneider and Hunke,
2002). Their other functions include signal transduction, protein secretion, antibiotic

9

resistance, antigen presentation, bacterial pathogenesis, and sporulation (Schneider and
Hunke, 2002). The secondary multidrug transporters fall into four superfamilies, including
the major facilitator superfamily , the small multidrug-resistance family, the multidrug and
toxic compound extrusion family, and the resistance-nodulation-cell division (RND)
superfamily (Fernández & Hancock, 2012).

Figure 2. Function of efflux pumps in the influx and efflux of antimicrobials in P.
aeruginosa. The figure is acquired through Li et al. (2015). Outer membrane [OM]; inner
membrane [IM]; OM channel protein [OMP]; membrane fusion protein [MFP].
Members of the RND family play a major role in antimicrobial resistance in P.
aeruginosa (Poole, 2011). An RND-type efflux system is a tripartite complex that consists of
a pump embedded in the inner membrane, the periplasmic adapter protein (or membrane
fusion protein), and the outer membrane channel (Figure 2) (Li et al., 2015). The RND
pumps are thought to take up the antibiotics from the periplasm and cooperate with singlecomponent or singlet pumps to extrude them out of the cell (Li et al., 2015).
Twelve RND-type efflux systems have been identified in P. aeruginosa (Poole,
2011), and four of these, MexAB-OprM, MexCD-OprJ, MexEF-OprN, and MexXY-OprM
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(OprA), make the most significant contribution to the multidrug-resistance in clinical isolates
(Li et al., 2015). The expression of P. aeruginosa RND-type efflux pump genes is induced in
response to various external stress factors including reactive oxygen species (MexAB-OprM,
MexXY-OprM), reactive nitrogen species (MexEF-OprN), membrane-damaging agents
(MexCD-OprJ), and ribosome-blocking substances (MexXY-OprM), (Lister et al., 2009;
Morita et al., 2014; Poole, 2014). MexAB-OprM is constitutively expressed in wild-type
strains and contributes to the intrinsic resistance to β-lactams and other antimicrobials (Poole
et al., 1993; Li et al., 1995; Yoneda et al., 2005). The MexXY-OprM pump also contributes
to the intrinsic resistance of P. aeruginosa to several agents such as fourth-generation
cephems, tetracyclines, erythromycin, and gentamicin (Yoneda et al., 2005). On the other
hand, the expression of MexCD-OprJ and MexEF-OprN is tightly regulated in wild-type P.
aeruginosa and their role is limited to acquired resistance (Kohler et al. 1997; Yoneda et al.,
2005).
2.6.

Efflux pump inhibitors (EPIs)

Efflux activity mediated by RND-type pumps contributes significantly to the intrinsic
drug resistance in many pathogenic microorganisms (Li et al., 2015). Thus the employment
of efflux pump inhibitors (EPIs) represents an attractive approach in counteracting the
multidrug resistance in P. aeruginosa and other Gram-negative pathogens (Askoura et al.,
2011). The synergistic application of antibiotics and EPIs reduces the invasiveness of P.
aeruginosa and the MICs of many antibiotics (Hirakata et al., 2009). The inhibition of efflux
pumps increases the intracellular drug concentration (Lomovskaya et al., 2001), restores the
drug activities against the resistant strains, and reduces the chance of the further development
of antibiotic resistance (Askoura et al., 2011).
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Carbonyl cyanide-mchlorophenyl hydrazone (CCCP)

Berberine

Epigallocatechin
gallate (EGCG)

Curcumin

Daidzein

Geraniol

Figure 3. Chemical structures of natural efflux pump inhibitors.
Several synthetic compounds have been reported to inhibit RND-type efflux pumps,
including phenyl-arginine-β-naphthylamide (PAβN), D13-9001, and MBX2319 (Li et al.,
2015). Although these EPIs increase the potency of various antibiotics against multidrugresistant pathogens, their clinical application is hindered by the high degree of cytotoxicity
(Li et al., 2015). Due to the constant exposure to bacteria in the soil, plants have developed
diverse defense systems and are therefore considered to be a promising source of new EPIs
with low toxicity and high tolerability (Prasch & Bucar, 2015). Over the last decade, various
plant-derived compounds with antimicrobial and efflux pump inhibitory activity have been
discovered (Prasch & Bucar, 2015). In this study, we tested the natural EPIs epigallocatechin
gallate, daidzein, berberine, curcumin and geraniol for synergistic activity with 4methoxybenzaldehyde against P. aeruginosa PAO1 (Figure 3).
Epigallocatechin gallate (EGCG) is the main polyphenol component of green tea,
which exhibits antibacterial activity and also inhibits the activity of bacterial gelatinase
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(Blanco et al., 2003), P-glycoprotein, and efflux pumps (Roccaro et al., 2004). Daidzein is an
isoflavone isolated from soybeans, which was shown to have an inhibitory effect on efflux
pumps of Mycobacterium smegmatis, P. aeruginosa and E. coli, as well as on P-glycoprotein
of cancer cells (Prasch & Bucar, 2015). Berberine is a natural benzylisoquinoline alkaloid
produced by plants of the Berberidaceae family. This compound has antimicrobial activity
and kills microorganisms by interacting with the cell division protein FtsZ (Boberek et al.,
2010) and inhibiting efflux pumps in Gram-positive bacteria (Morita et al., 2016). Geraniol is
isolated from Geranium species and was shown to be a potent EPI in Gram-negative bacteria
(Lorenzi et al., 2009). Lastly, curcumin is extracted from rhizomes of the plant Curcuma
longa (Zingiberaceae) and has multiple biological activities such as anti-inflammatory,
antiviral, antioxidant, anticancer, and inhibition of the expression of efflux pumps (Negi et
al., 2014).

3. Materials and Methods
3.1.

Bacterial strain, growth conditions and compounds

Pseudomonas aeruginosa PAO1 was used in all experiments listed in this study. The
strain was routinely cultured in Luria-Bertani (LB) medium (Difco), while Mueller-Hilton II
(MH) broth and agar (Becton, Dickinson and Co.) were used for all antimicrobial assays.
Cultures were grown at 37 °C with shaking at 220 rpm where necessary. The selection of
transposon mutants was performed by amending the growth medium with tetracycline (Tc)
(Affymetrix) at the concentration of 100 μg/mL. The stock solution of 4methoxybenzaldehyde (Fischer Scientific) was prepared by ultrasonicating the compound for
5 min in 0.2% (w/v) agar. The stock concentrations of EGCG (10 mg/ml), geraniol (5
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mg/ml), daidzein (5 mg/ml), berberine (2 mg/ml), and curcumin (5 mg/ml) were prepared by
dissolving the chemicals in dimethylsulfoxide (DMSO; Alfa Aesar).
3.2.

Transposon mutagenesis and screening of the mutants

Electrocompetent cells of P. aeruginosa PAO1 were prepared using a modified
procedure of Choi et al. (2006). Six milliliters of an overnight culture in LB medium were
aliquoted into four microcentrifuge tubes and centrifuged at room temperature for 2 min at
16,000 x g. The cells were washed twice with 1 mL of 300 mM sucrose, and each cell pellet
was resuspended in 25 μL of 300 mM sucrose and combined in one tube. The transposon
mutagenesis was performed with the EZ-Tn5™ Transposomes (Epicentre) following the
manufacturer’s instruction. Briefly, 0.7 μL of the transposome was added to 100 μL of
electrocompetent cells, and the mixture was transferred to a 2 mm gap width electroporation
cuvette. After applying a pulse (2.5 kV, 10 μF, 600 Ω) with an Electroporator 2510
(Eppendorf) the cells were immediately mixed with one milliliter of room temperature LB
medium and transferred to a glass tube (16 x 150 mm). The transformants were incubated for
1.5 hours at 37 °C with shaking at 250 rpm. The cells were then diluted 1:10 in LB medium
and 100 μL of the suspension were spread-plated onto an LB-Tc100 plate. The plates were
incubated at 37 °C for 24 hours or until colonies appeared. Negative controls included cells
electroporated without the EZ-Tn5 transposome mixture.
The resultant transposon-bearing clones (confirmed via PCR) were transferred into
wells of 96-well microplates pre-filled with 100 μL of MH medium. The transposon mutant
library was incubated at 37 °C for 24 hours and replicated with a 96-prong replicator (VP
Scientific) into new microplates containing MH medium with 0.2% agar amended with 4methoxybenzaldehyde at 1.2, 1.5, and 1.7 mg/mL concentrations, respectively. The
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inoculated microplates were incubated at 37 °C for 24 hours, and bacterial growth was
recorded by measuring optical density at 600 nm (OD600) using a Synergy 2 reader (Biotek).
Cultures grown in the unamended MH medium were mixed with dimethyl sulfoxide (7%
final), and frozen at −80 °C for long-term storage. Assays were repeated twice with three
replicates for each treatment condition. The cultures of transposon mutants that had grown to
an OD600 < 0.05 were selected as sensitive mutants. From the second screening, the factor of
inhibition (F1) of 4-methoxybenzaldehyde was calculated by dividing OD600 of the untreated
culture by that of the treated culture for each mutant (Campen et al., 2015).
3.3.

Mapping of Tn5 transposon insertions by inverse PCR and sequencing

Genomic DNA was extracted from overnight LB cultures of the sensitive mutants
using a DNeasy UltraClean Microbial Kit (Qiagen), and 250-ng aliquots of the DNA samples
obtained were digested with the restriction endonuclease SacII (New England Biolabs). The
reactions were incubated for 3 hours at 37 °C, and the enzyme was inactivated at 65 °C for
20 min. The digested DNA was self-ligated by incubating it overnight at 16 °C in the
presence of T4 DNA ligase (New England Biolabs).
The ligation products served as templates for inverse PCR with the Q5 High-Fidelity
DNA Polymerase (New England Biolabs) and transposon-specific primers (Table 1;
Eurofins) (Amato et al., 2018). Cycling conditions included 98 °C for 30 s, followed by 34
cycles of 98 °C for 10 s, 72 °C for 2 min and 72 °C for 2 min, and a final extension at 72 °C
for 5 min. The PCR products were analyzed by gel electrophoresis (1% w/v agarose gel, 120
V, 20 min) and amplicons were purified using a GeneJET PCR Purification Kit (Thermo
Scientific). The purified DNA was sequenced by Eurofins USA, and areas flanking the EZ-
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Tn5 <TET-1> integration sites were mapped to the P. aeruginosa PAO1 genome using the
BLASTn web tool of the Pseudomonas database (Winsor et al., 2016).

Table 1. Oligonucleotide primers used in the inverse PCR.
Primer
Primer or probe
TET-1FP-3 5’-GCATCTCGGGCACGTTGGGTCCT-3’
TET-1RP-4 5’-CGAGGATGACGATGAGCGCATTGTTAG-3’

3.4.

Reference
EZ-Tn5™ <TET-1>
Insertion Kit, Epicentre

Testing interactions of efflux pump inhibitors (EPIs) with 4methoxybenzaldehyde

The interactions of 4-methoxybenzaldehyde with EPIs were tested using a modified
broth microdilution technique with bacteria cultured in MH broth supplemented with noninhibitory concentrations of EGCG (150 µg/mL), daidzein (1 mg/mL), curcumin (400
µg/mL), berberine (400 µg/mL), geraniol (600 µg/mL), and the uncoupler of proton motive
force carbonyl cyanide m-chlorophenylhydrazone (CCCP) (25 µg/mL), respectively. The
MIC of 4-methoxybenzaldehyde against P. aeruginosa PAO1 was determined in the
presence and absence of each of these compounds. Bacteria suspended in unamended MH
medium served as a positive control, while MH medium mixed with 4-methoxybenzaldehyde
in 0.2% agar was used as a negative control. Microtiter plates were then incubated at 37 °C
for 24 hours and OD600 of the cultures were measured to determine the nature of interactions
(OD600 < 0.05 were considered negative for bacterial growth). Each experiment was repeated
three times with three replicates for each treatment.
3.5.

Using RT-qPCR to measure the effect of 4-methoxybenzaldehyde and EGCG
on the expression of RND-type efflux pump genes

The expression of mexA, mexC, mexE, mexX, and rpoD was determined with
quantitative reverse transcription PCR (RT-qPCR) using antimicrobial exposure and RNA
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extraction protocols adapted from Liu et al. (2017). An overnight culture was diluted to an
OD600 of 0.01 in MH medium and incubated at 37 °C in a 96-well microtiter plate. At an
OD600 of 0.6, the culture was treated with 4-methoxybenzaldehyde (1 mg/mL), EGCG (150
μg/mL), and the combination of 4-methoxybenzaldehyde (0.5 mg/mL) and EGCG (150
μg/mL) prepared in MH medium. Each treatment had three independent biological replicates.
The control culture was amended MH medium ultrasonicated for 5 min to standardize the
conditions.
After 1 hour of exposure at 37 °C, approximately 2.5 x 108 cells were fixed by mixing
with two volumes of RNAprotect Bacteria reagent (Qiagen), and total RNA was extracted
using an RNeasy Mini Kit (Qiagen) according to the manufacturer’s instructions. Total RNA
was treated at 37 °C for 30 min with DNase I (Ambion) and purified using RNA Clean and
Concentrator columns (Zymo Research). The concentration and purity of RNA samples were
determined using the QuantiFlour RNA System (Promega). cDNA was synthesized from 1
μg of total RNA using the iScript Reverse Transcription Supermix (Bio-Rad), and RT-qPCR
was performed with the Luminaris Probe qPCR Master Mix (Thermo Scientific) according to
the manufacturer’s instructions. The analysis was performed using a CFX96 Real-Time PCR
Detection System and CFX Maestro software (Bio-Rad). RNA samples not treated with
reverse transcriptase served as a negative control to ensure the absence of contaminating
genomic DNA. The primers and probes used for RT-qPCR studies are listed in Table 2
(Quale et al., 2006) The expression of mRNA for the genes of interest was normalized to that
of the housekeeping gene rpoD. This gene was shown to be constitutively expressed in P.
aeruginosa (Salvi et al., 2003; Quale et al., 2006).
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Table 2. Oligonucleotide primers and probes used in the RT-qPCR experiment.
Gene

NCBI
Accession

rpoD

Primer or probe

Reference

NP_249267.1

Fwd
Rev
Probe

5'-GGGCTGTCTCGAATACGTTGA-3'
5'-ACCTGCCGGAGGATATTTCC-3'
[DFAM]TGCGGATGATGTCTTCCACCTGTTCC[DTAM]

Quale et al.,
2006

mexA

NP_249116.1

Fwd
Rev
Probe

5'-AACCCGAACAACGAGCTG-3'
5'-ATGGCCTTCTGCTTGACG-3'
[DFAM]CATGTTCGTTCACGCGCAGTTG[DTAM]

Quale et al.,
2006

mexC

NP_253289.1

Fwd
Rev
Probe

5'-GGAAGAGCGACAGGAGGC-3'
5'-CTGCACCGTCAGGCCCTC-3'
[DFAM]CCGAAATGGTGTTGCCGGTG[DTAM]

Quale et al.,
2006

mexE

NP_251183.1

Fwd
Rev
Probe

5'-TACTGGTCCTGAGCGCCT-3'
5'-TCAGCGGTTGTTCGATGA-3'
[DFAM]CGGAAACCACCCAAGGCATG[DTAM]

Quale et al.,
2006

5'-GGCTTGGTGGAAGACGTG-3'

Quale et al.,
2006

Part of a
Fwd
genome
Rev
record
NC_002516
Probe
Fwd, forward; Rev, reverse.
mexX

5'-GGCTGATGATCCAGTCGC-3'
[DFAM]CCGACACCCTGCAGGGCC[DTAM]

4. Results
4.1.

Sensitive transposon mutants and the corresponding defective genes

Previously, a smaller transposon mutant library of P. aeruginosa PAO1 was
generated and screened for the sensitivity to 4-methoxybenzaldehyde. That screen revealed
that disruption of the RND pump gene mexA increased the sensitivity of P. aeruginosa to 4methoxybenzaldehyde (Amato et al., 2018). We hypothesized that generation of additional
transposon mutants would help to identify other cellular pathways that mediate resistance to
phytoaldehydes. To this end, we generated and screened 7,000 mutants of P. aeruginosa
PAO1, bringing the size of the transposon mutant library to 10,000 clones. Using the genome
coverage formula of 𝑚 = 1 − 𝑒 −𝐿/𝐺 (Campen et al., 2015) for a given size of library (L), the
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number of unique mutants (m), and the number of genes (G), we estimate that our transposon
library covered approximately 83% of P. aeruginosa genes.
Pseudomonas aeruginosa PAO1 was transformed with EZ-Tn5 transposomes, and the
efficiency of transposon insertion was calculated to be between 1 x 105 and 1 x 108 colony
forming unit/μg. Mutants were screened against sub-inhibitory concentrations of 4methoxybenzaldehyde (1.2, 1.5 and 1.7 mg/mL). We then selected the mutants that grew
(OD600 > 0.05) in the control medium but not in the medium amended with 4methoxybenzaldehyde as sensitive. An example of a sensitive mutant is shown in Figure 4. In
total, we identified the disrupted genes of 25 mutants with increased sensitivity to 4methobenzaldehyde. The transposon insertion sites in the sensitive mutants were mapped,
and the sequences were annotated.
A.

B.

Factor of Inhibition (F1)

C.

25
20
15
10
5
0
0

50

100

Mutant number

Figure 4. Selection of hypersensitive mutants. Mutants that grew in (A) control medium but
did not grow in (B) medium supplemented with 1.5 mg/mL of 4-methoxybenzaldehyde were
selected as hypersensitive. (C) The mutants with F1 of 9 and above are defined as
hypersensitive.
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The sensitive mutants, genes disrupted by transposon insertions, and their putative
functions are summarized in Table 3. The major cellular pathways involved in the interaction
of P. aeruginosa with 4-methoxybenzaldehyde included multiple components of the cell
envelope, as well as proteins involved in the transport of molybdenum and biosynthesis of
molybdenum cofactor, energy metabolism, nucleotide biosynthesis, and two-component
regulatory systems. A significant proportion (24%) of the recovered mutants had a defect in
genes encoding conserved hypothetical proteins. Mutations in energy metabolism and
nucleotide biosynthesis genes resulted in the highest sensitivity to 4-methobenzaldehyde (1.2
mg/mL). The nqrE, moeB, nqrF, and ccoN1 mutants failed to grow in the presence of 1.5
mg/mL, while the rest of the mutants stopped growing at 1.7 mg/mL 4methoxybenzaldehyde.
Table 3. Genes disrupted by EZ-Tn5 in mutants with sensitivity to 4-methoxybenzaldehyde.
Mutant

ORF (Disrupted
gene)

Function

Functional category

218

PA0590 (apaH)

Bis(5'-nucleosyl)-tetraphosphatase

Nucleotide biosynthesis and
metabolism, purine metabolism

144

PA0928 (gacS)

Sensor/response regulator hybrid

184*

PA1554 (ccoN1)

Cytochrome C oxidase, cbb3-type,
CcoN subunit

Two component regulatory system,
biofilm formation
Central intermediary metabolism,
Energy metabolism

219, 239,
169

PA1861 (modC)

Molybdenum transport protein
ModC

Transport of small molecules, ABC
transporters

171

PA1862 (modB)

Transport of small molecules

186, 201

PA1880

Molybdenum transport protein
ModB
Probable oxidoreductase

161**

PA2991 (sth)

191

PA2993

Soluble pyridine nucleotide
transhydrogenase
Conserved hypothetical protein

209, 217*,
237

PA2994 (nqrF)

Na+-translocating NADH:quinone
oxidoreductase, subunit Nqr6

Nucleotide biosynthesis and
metabolism
Unknown, thiamine diphosphate
biosynthesis
Energy metabolism, Polycyclic
aromatic hydrocarbon degradation

146*

PA2995 (nqrE)

Na+-translocating NADH:quinone
oxidoreductase subunit Nqr5
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Putative enzymes

Energy metabolism

Na+-translocating
NADH:ubiquinone oxidoreductase
subunit Nrq1
Aromatic amino acid transport
protein AroP1
Molybdopterin biosynthetic
protein B2

215, 216**

PA2999 (nqrA)

Energy metabolism

188

PA3000 (aroP1)

151

PA3029 (moaB2)

197

PA3271

Probable two-component sensor

Biosynthesis of cofactors, prosthetic
groups and carriers, molybdopterin
biosynthesis
Two component regulatory system

190

PA4617

Hypothetical protein

Unknown

170

PA4618

Hypothetical protein

Unknown

155*

PA4663 (moeB)

Molybdopterin biosynthesis MoeB
protein

196

PA4856 (retS)

143

PA5339

RetS (Regulator of
exopolysaccharide and Type III
secretion)
Conserved hypothetical protein

Biosynthesis of cofactors, prosthetic
groups and carriers, sulfur relay
system
Two-component regulatory systems,
biofilm formation

Transport of small molecules

Unknown

**Sensitive to 1.2 mg/mL of 4-methoxybenzaldehyde;*sensitive to 1.5 mg/mL of 4-methoxybenzaldehyde; the
rest of the mutants were sensitive to 1.7 mg/mL of 4-methoxybenzaldehyde.

4.2.

Interaction of efflux pump inhibitors (EPIs) with 4-methoxybenzaldehyde

Although the transposon mutagenesis did not yield any additional efflux pump
mutants, we proceeded to test the effect of EPIs on the susceptibility of P. aeruginosa PAO1
to 4-methoxybenzaldehyde based on the previous result by Amato et al. (2018). We exposed
bacterial suspensions to non-inhibitory concentrations of plant-derived EPIs and determined
their effect on MICs of 4-methoxybenzaldehyde.
Results of these assays are summarized in Table 4 and show that daidzein did not
affect the MIC of 4-methoxybenzaldehyde, while berberine, curcumin, and geraniol
exhibited partial synergism by moderately decreasing the MIC values. In contrast, the
treatment of P. aeruginosa with the synthetic efflux pump inhibitor CCCP (uncouples proton
motive force) significantly reduced the MIC of 4-methoxybenzaldehyde. A similar effect was
observed with EGCG, which was the most effective natural EPI and improved the efficacy of
4-methoxybenzaldehyde by 60% (Table 4). As CCCP and EGCG showed the most robust
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synergistic interaction with 4-methoxybenzaldehyde, we tested the MIC of 4methoxybenzaldehyde in the presence of both EPIs with mexA mutant from the transposon
mutant library generated by Amato et al. (2018).
Table 4. The effect of EPIs on MIC of 4-methoxybenzaldehyde and their interactions in
wild-type P.aeruginosa PAO1.
EPI
None
CCCP
EGCG
Daidzein
Berberine
Curcumin
Geraniol

Concentration
(μg/mL)
N/A
25
150
400
400
400
400

MIC of 4-methoxybenzaldehyde
(mg/mL)
2.0
0.6
0.8
2
1.5
1.5
1.5

Interaction
N/A
Synergism
Synergism
Indifference
Partial synergism
Partial synergism
Partial synergism

Our findings confirmed that CCCP and EGCG potentiate the antimicrobial activity of
4-methoxybenzaldehyde both in the wild-type strain and the mexA mutant derivative.
Importantly, we showed that only 30% and 40% of the total amount of 4methoxybenzaldehyde usually required to inhibit P. aeruginosa was needed to effectively

MIC of 4-methoxybenzaldehyde
(mg/mL)

suppress the bacterial growth in the presence of CCCP and EGCG, respectively (Figure 5).
No EPI
2.5

CCCP
EGCG

2.0
1.5
1.0
0.5
0.0
Wild-type

mexA

oprF

Figure 5. MICs of 4-methoxybenzaldehyde in the presence of cyanide m-chlorophenyl
hydrazine (CCCP) (25 µg/mL) and EGCG (150 μg/mL) for P.aeruginosa PAO1 mexA
mutant.
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4.3.

The response of RND-type efflux pump gene expression to 4methoxybenzaldehyde and EGCG

As EPIs sensitized P. aeruginosa PAO1 and its mutants to 4-methoxybenzaldehyde,
we proceeded to investigate if 4-methoxybenzaldehyde and EGCG perturb the expression of
the genes contributing to the intrinsic and acquired types of resistance to antimicrobial
compounds. We exposed the wild-type P. aeruginosa to 4-methoxybenzaldehyde, EGCG,
and the combination of both compounds, and used RT-qPCR with specific primers and
probes targeting genes encoding MexAB-OprM and components of other clinically-relevant
RND-type efflux pumps (i.e., MexCD-OprJ, MexEF-OprN, and MexXY-OprM).
Results of this experiment revealed that 4-methoxybenzaldehyde induced the mexC
and mexE genes by 54- and 21-fold, respectively, compared to the untreated control. In
contrast, the addition of EGCG significantly decreased the expression of mexC and mexE,
which were upregulated only by 18- and 12-fold, respectively, relative to the control (Figure
6). EGCG alone caused a slight (3.1-fold) upregulation of the mexA gene but did not affect
levels of expression of other efflux genes.
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Figure 6. Relative expression of RND-type efflux pump genes in response to 4methoxybenzaldehyde, EGCG and a combination of both compounds. Tukey-Kramer HSD
test was used for statistical analysis. The significant difference represents the comparison
between treatments for each gene.

5. Discussion
The increasing interest in medical applications of antimicrobial EO constituents has
led to the exploration of their molecular interactions with many important pathogens.
Previously, Amato et al. (2018) showed that mexA mutants from the transposon mutant
library of P. aeruginosa PAO1 were hypersensitive to 4-methoxybenzaldehyde. This finding
prompted us to expand the transposon screen in the hope of identifying more genes
responsible for susceptibility to 4-methoxybenzaldehyde. The results of this screen revealed
that the exposure of P. aeruginosa PAO1 to 4-methoxybenzaldehyde affects a diverse range
of cytoplasmic and membrane pathways, including those involved in various transport
functions, the central intermediary metabolism, energy metabolism, and biosynthesis of
cofactors. We discovered that six out of 25 susceptible mutants contained transposon
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insertions in genes encoding subunits of a Na+-translocating NADH:quinone oxidoreductase.
These results were consistent with the findings of Yu et al. (2010), who showed that 4methoxybenzaldehyde upregulates the gene encoding an aryl-alcohol dehydrogenase
involved in the oxidoreductase activity in Saccharomyces cerevisiae. The recovery of
mutations in genes for the transport of molybdenum and synthesis of the molybdenum
cofactor supported the study from Amato et al. (2018), which also observed multiple
hypersensitive mutants that were deficient in these pathways. Currently, no evidence in the
literature can explain the connection between the molybdenum cofactor pathways and 4methoxybenzaldehyde, which warrants further investigation of these mutants. Interestingly,
we also found that some hypersensitive phenotypes were associated with mutations in
regulatory genes, such as the global two-component regulatory system GacAS. In P.
aeruginosa, the GacAS system contributes to the formation of biofilms, secretion of
secondary metabolites, and resistance to some antibiotics (Brinkman et al., 2001). However,
the antibiotic resistance mechanism mediated by GacAS is unclear (Gooderham & Hancock,
2009). Finally, we found several hypersensitive mutants that were deficient in the production
of conserved hypothetical proteins which play an unknown role in the biology of P.
aeruginosa.
We also tested several plant-derived efflux pump inhibitors (EPIs) for the capacity to
improve the antimicrobial efficacy of 4-methoxybenzaldehyde. Results of this testing
revealed that epigallocatechin gallate (EGCG) from green tea acted synergistically and
significantly reduced the minimal inhibitory concentration of 4-methoxybenzaldehyde. Our
findings agreed with the data of Roccaro et al., (2004), who reported that EGCG interfered
with the function of efflux pumps in S. aureus. The mechanism behind this interference
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remains unclear, and it has been suggested that EPIs may inhibit efflux by interfering with
the expression of efflux pump genes, disrupting the assembly of the efflux pump
components, or by interfering with the energy source of efflux pumps (Askoura et al., 2011).
Finally, we measured the expression of genes encoding transfusion membrane proteins of
RND-type efflux pumps MexAB-OprM, MexCD-OprJ, MexEF-OprN, and MexXY-OprM in
response to 4-methoxybenzaldehyde and EGCG. We found that 4-methoxybenzaldehyde
significantly upregulated components of the MexCD-OprJ and MexEF-OprN efflux pumps,
which are known to act on aromatic hydrocarbons and may thus recognize 4methoxybenzaldehyde as a substrate (Askoura et al., 2011). The induction of mexC and mexE
in the presence of 4-methoxybenzaldehyde and EGCG was significantly lower, thus
suggesting that EGCG has a suppressive effect on the expression of these genes. The mexX
gene did not respond to any of the treatments, indicating that 4-methoxybenzaldehyde may
not be an essential substrate for this pump under the tested experimental conditions.

6. Conclusion
In summary, this study has demonstrated that antimicrobial phytoaldehydes kill
bacteria by perturbing different classes of cellular pathways, including components of RNDtype efflux pumps, which also play an important role in the resistance to different types of
clinical antibiotics. The susceptibility to phytoaldehydes can be improved by treating P.
aeruginosa with synthetic and natural efflux pump inhibitors. In particular, we demonstrated
that the natural EPI epigallocatechin gallate (EGCG) interacts synergistically with 4methoxybenzaldehyde. Collectively, our results highlighted the importance of active efflux in
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the resistance of P. aeruginosa to phytoaldehydes and the potential of EPIs in improving the
efficacy of these natural antimicrobials and phytoaldehyde-based PANDAs.
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